Cover Image
市場調查報告書

POC診斷 (照護現場診斷) 的全球市場:2015∼2019年

Global POC Diagnostics Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 325006
出版日期 內容資訊 英文 104 Pages
訂單完成後即時交付
價格
Back to Top
POC診斷 (照護現場診斷) 的全球市場:2015∼2019年 Global POC Diagnostics Market 2015-2019
出版日期: 2015年02月25日 內容資訊: 英文 104 Pages
簡介

所謂POC (Point of Care:照護現場) 診斷,在臨床試驗室以外環境下,為了診斷患者患的疾病所使用的體外診斷 (IVD) 用設備、工具。使用這樣的設備,可迅速診斷患者的症狀,提供適當的治療和藥物。為了使POC診斷具成本效率性且容易使用,還有抑制診斷中的錯誤發生,而進行了標準化。由於文明病 (糖尿病、肥胖症、心臟疾病等) 和感染疾病的患病人數增加,POC診斷的使用頻率變得非常高。POC診斷還使用於臨床診斷的各種領域 (血糖值檢驗和血液凝固檢查、傳染病檢查、心臟標記診斷、妊娠、妊娠能力檢驗、血中氣體/電解質檢驗、腫瘤標記檢驗、尿液檢查、膽固醇檢驗等) 。全球POC診斷市場,預計2014∼2019年,以8.47%的年複合成長率成長。

本報告提供全球的照護現場診斷 (POC診斷) 市場相關分析、市場概要和結構、市場規模趨勢 (今後5年的預測值)、各地區的詳細趨勢、推動、阻礙市場要素與其影響力、主要企業簡介、今後的市場機會等調查、考察。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 美國的POC診斷市場
  • 歐洲的POC診斷市場
  • 波特的五力分析

第7章 各用途的市場區隔

  • 全球血糖檢驗市場
  • 全球傳染病檢查市場
  • 全球心臟標記測試市場
  • 全球血液凝固檢驗市場
  • 全球妊娠、妊娠能力檢驗市場
  • 全球血氣/電解質檢驗市場
  • 全球腫瘤標記檢驗市場
  • 全球尿液檢查市場
  • 全球膽固醇檢驗市場

第8章 地區區分

  • 南北美洲的POC診斷市場
  • 歐洲、中東、非洲地區 (EMEA) 的POC診斷市場
  • 亞太地區的POC診斷市場

第9章 購買標準

第10章 推動市場成長要素

第11章 成長推動因素與其影響

第12章 市場課題

第13章 成長推動因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭模式
    • 主要消息
    • 企業合併、收購 (M&A)
  • 供應商分析
  • 其他卓越供應商

第17章 主要供應商分析

  • Abbott Laboratories
    • 主要資料
    • 產業概要
    • 各部門的市場收益額
    • 各部門的市場收益額 (過去的實際成果值)
    • 各地區的市場收益額
    • 產業策略
    • 主要資訊
    • SWOT分析
  • Alere
  • Bayer HealthCare
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson

第18章 相關報告

圖表一覽

目錄
Product Code: IRTNTR5374

About POC Diagnostics

POC diagnostics are IVD devices and tools used for diagnosing diseases in patients outside a clinical laboratory setting. The use of these devices helps in the rapid diagnosis of the medical conditions and aids in providing appropriate treatments and medication to patients. They are cost-effective, user-friendly, and standardized to minimize errors during diagnosis. They are being used extensively for diagnostic purposes owing to the high prevalence of lifestyle diseases such as diabetes and obesity, cardiac disorders, and infectious diseases. They have a wide range of applications in clinical diagnosis such as the testing of blood glucose and coagulation, infectious diseases, cardiac markers, pregnancy and fertility, blood gas/electrolytes, tumor markers, urinalysis, and cholesterol.

TechNavio's analysts forecast the Global POC Diagnostics market to grow at a CAGR of 8.47 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global POC Diagnostics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC diagnostics used in various applications:

  • Blood glucose testing
  • Infectious diseases testing
  • Cardiac markers testing
  • Coagulation testing
  • Pregnancy and fertility testing
  • Blood gas/electrolytes testing
  • Tumor markers testing
  • Urinalysis testing
  • Cholesterol testing

TechNavio's report, the Global POC Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Alere
  • Bayer Healthcare
  • Danaher
  • F. Hoffmann-La Roche
  • Johnson & Johnson

Other Prominent Vendors

  • A. Menarini Diagnostics
  • Abaxis
  • Acon
  • BD
  • Bio-Rad Laboratories
  • Chembio Diagnostics
  • Chongqing Haray International Business
  • Clarity Diagnostics
  • Clinical Innovations
  • Contec Medical
  • Eurotrol
  • Fudakang Ind'l
  • Helena Laboratories
  • i-sens
  • International Technidyne
  • Medtronic
  • Nipro Diagnostics
  • Nova Biomedical
  • OraSure Technologies
  • Phamatech
  • Quidel
  • Radiometer Medical
  • Randox Laboratories
  • SA Scientific
  • Sekisui Diagnostics
  • Shenzhen Fitconn Technology
  • Siemens Healthcare
  • STAT Technologies
  • Streck
  • TaiDoc
  • Trinity Biotech
  • Urit Medical

Market Driver

  • High Prevalence of Diabetes and Obesity
  • For a full, detailed list, view our report

Market Challenge

  • Limitation of POC Diagnostics
  • For a full, detailed list, view our report

Market Trend

  • Rapid Adoption of POC Diagnostic Tests
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. POC Diagnostics Market in US
    • 06.3.1. Market Size and Forecast
  • 06.4. POC Diagnostics Market in Europe
    • 06.4.1. Market Size and Forecast
  • 06.5. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Global Blood Glucose Testing Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Infectious Diseases Testing Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Cardiac Markers Testing Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global Coagulation Testing Market
    • 07.4.1. Market Size and Forecast
  • 07.5. Global Pregnancy and Fertility Testing Market
    • 07.5.1. Market Size and Forecast
  • 07.6. Global Blood Gas/Electrolytes Testing Market
    • 07.6.1. Market Size and Forecast
  • 07.7. Global Tumor Markers Testing Market
    • 07.7.1. Market Size and Forecast
  • 07.8. Global Urinalysis Testing Market
    • 07.8.1. Market Size and Forecast
  • 07.9. Global Cholesterol Testing Market
    • 07.9.1. Market Size and Forecast

08. Geographical Segmentation

  • 08.1. POC Diagnostics Market in Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. POC Diagnostics Market in EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. POC Diagnostics Market in APAC Region
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Vendor Analysis 2014
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Abbott Laboratories
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation by Revenue
    • 17.1.4. Business Segmentation by Revenue 2011 and 2012
    • 17.1.5. Geographical Segmentation by Revenue
    • 17.1.6. Business Strategy
    • 17.1.7. Key Information
    • 17.1.8. SWOT Analysis
  • 17.2. Alere
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation by Revenue 2013
    • 17.2.4. Business Segmentation by Revenue 2012 and 2013
    • 17.2.5. Geographical Segmentation by Revenue 2013
    • 17.2.6. Business Strategy
    • 17.2.7. Recent Developments
    • 17.2.8. SWOT Analysis
  • 17.3. Bayer HealthCare
    • 17.3.1. Key Facts
    • 17.3.2. Business Overview
    • 17.3.3. Business Segmentation by Revenue 2013
    • 17.3.4. Business Segmentation by Revenue 2012 and 2013
    • 17.3.5. Geographical Segmentation by Revenue 2013
    • 17.3.6. Business Strategy
    • 17.3.7. Recent Developments
    • 17.3.8. SWOT Analysis
  • 17.4. Danaher
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Business Segmentation
    • 17.4.4. Revenue by Business Segmentation
    • 17.4.5. Revenue Comparison 2012 and 2013
    • 17.4.6. Segmentation by Geography
    • 17.4.7. Business Strategy
    • 17.4.8. Key Information
    • 17.4.9. SWOT Analysis
  • 17.5. F. Hoffmann-La Roche
    • 17.5.1. Key Facts
    • 17.5.2. Business Overview
    • 17.5.3. Business Segmentation
    • 17.5.4. Geographical Segmentation by Revenue 2013
    • 17.5.5. Business Strategy
    • 17.5.6. Key Information
    • 17.5.7. SWOT Analysis
  • 17.6. Johnson & Johnson
    • 17.6.1. Key Facts
    • 17.6.2. Business Overview
    • 17.6.3. Business Segmentation by Revenue 2013
    • 17.6.4. Business Segmentation by Revenue 2012 and 2013
    • 17.6.5. Geographical Segmentation by Revenue 2013
    • 17.6.6. Business Strategy
    • 17.6.7. Recent Developments
    • 17.6.8. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global POC Diagnostics Market 2014-2019 (US$ million)
  • Exhibit 3: POC Diagnostics Market in US 2014-2019 (US$ million)
  • Exhibit 4: POC Diagnostics Market in Europe 2014-2019 (US$ million)
  • Exhibit 5: Segmentation of Global POC Diagnostics Market by Application
  • Exhibit 6: Global POC Diagnostics Market by Application 2014
  • Exhibit 7: Global Blood Glucose Testing Market 2014-2019 (US$ million)
  • Exhibit 8: Global Infectious Diseases Testing Market 2014-2019 (US$ million)
  • Exhibit 9: Global Cardiac Markers Testing Market 2014-2019 (US$ million)
  • Exhibit 10: Global Coagulation Testing Market 2014-2019 (US$ million)
  • Exhibit 11: Global Pregnancy and Fertility Testing Market 2014-2019 (US$ million)
  • Exhibit 12: Global Blood Gas/Electrolytes Testing Market 2014-2019 (US$ million)
  • Exhibit 13: Global Tumor Markers Testing Market 2014-2019 (US$ million)
  • Exhibit 14: Global Urinalysis Testing Market 2014-2019 (US$ million)
  • Exhibit 15: Global Cholesterol Testing Market 2014-2019 (US$ million)
  • Exhibit 16: Segmentation of Global POC Diagnostics Market by Application 2014-2019 (US$ million)
  • Exhibit 17: Segmentation of Global POC Diagnostics Market by Application 2014-2019
  • Exhibit 18: Geographical Segmentation of Global POC Diagnostics Market 2014
  • Exhibit 19: POC Diagnostics Market in Americas 2014-2019 (US$ million)
  • Exhibit 20: POC Diagnostics Market in EMEA Region 2014-2019 (US$ million)
  • Exhibit 21: POC Diagnostics Market in APAC Region 2014-2019 (US$ million)
  • Exhibit 22: Geographical Segmentation of Global POC Diagnostics Market 2014-2019 (US$ million)
  • Exhibit 23: Geographical Segmentation of Global POC Diagnostics Market 2014-2019
  • Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 25: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 26: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 27: Global POC Diagnostics Market: Business Segmentation by Revenue 2013
  • Exhibit 28: Global POC Diagnostics Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 29: Global POC Diagnostics Market: Geographical Segmentation by Revenue 2013
  • Exhibit 30: Bayer HealthCare: Business Segmentation by Revenue 2013
  • Exhibit 31: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 32: Bayer HealthCare: Geographical Segmentation by Revenue 2013
  • Exhibit 33: Danaher: Business Segmentation
  • Exhibit 34: Danaher: Business Segmentation 2013
  • Exhibit 35: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 36: Danaher: Revenue by Geographical Segmentation 2013
  • Exhibit 37: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 38: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 39: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
  • Exhibit 40: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
  • Exhibit 41: Johnson & Johnson: Business Segmentation by Revenue 2013
  • Exhibit 42: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 43: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Back to Top